{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:02:06Z","timestamp":1779922926992,"version":"3.53.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.lfs.2009.01.017","type":"journal-article","created":{"date-parts":[[2009,2,9]],"date-time":"2009-02-09T13:16:35Z","timestamp":1234185395000},"page":"552-557","source":"Crossref","is-referenced-by-count":28,"title":["Accelerative effect of leflunomide on recovery from hepatic fibrosis involves TRAIL-mediated hepatic stellate cell apoptosis"],"prefix":"10.1016","volume":"84","author":[{"given":"Xiaoming","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.lfs.2009.01.017_bib1","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/gut.2005.067801","article-title":"Following the TRAIL from hepatitis C virus and alcohol to fatty liver","volume":"54","author":"Afford","year":"2005","journal-title":"Gut"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2009.01.017_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000091465","article-title":"The active form of leflunomide, HMR1726, facilitates TNF-alpha and IL-17 induced MMP-1 and MMP-3 expression","volume":"17","author":"Alexander","year":"2006","journal-title":"Cellular Physiology Biochemistry"},{"issue":"3","key":"10.1016\/j.lfs.2009.01.017_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2001-17558","article-title":"Hepatic stellate cells as a target for the treatment of liver fibrosis","volume":"21","author":"Bataller","year":"2001","journal-title":"Seminars in Liver Disease"},{"issue":"3","key":"10.1016\/j.lfs.2009.01.017_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2001-17552","article-title":"Extracellular matrix degradation and the role of hepatic stellate cells","volume":"21","author":"Benyon","year":"2001","journal-title":"Seminars in Liver Disease"},{"issue":"1","key":"10.1016\/j.lfs.2009.01.017_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keg038","article-title":"The active metabolite of leflunomide, A771726, inhibits the production of prostaglandin E2, matrix metalloproteinase 1 and interleukin 6 in human fibroblast-like synoviocytes","volume":"42","author":"Burger","year":"2003","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.lfs.2009.01.017_bib6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.it.2005.07.007","article-title":"TNF-blocking therapies: an alternative mode of action?","volume":"26","author":"Choo-Kang","year":"2005","journal-title":"Trends in Immunology"},{"issue":"4","key":"10.1016\/j.lfs.2009.01.017_bib7","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/bi952168g","article-title":"The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase","volume":"35","author":"Davis","year":"1996","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.lfs.2009.01.017_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI200522675","article-title":"Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair","volume":"115","author":"Duffield","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.lfs.2009.01.017_bib9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/gast.2002.35384","article-title":"Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells","volume":"123","author":"Fischer","year":"2002","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.lfs.2009.01.017_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/clim.1999.4777","article-title":"Mechanism of action for leflunomide in rheumatoid arthritis","volume":"93","author":"Fox","year":"1999","journal-title":"Clinical Immunology"},{"issue":"1","key":"10.1016\/j.lfs.2009.01.017_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1172\/JCI200523928","article-title":"Mac the knife? Macrophages \u2014 the double-edged sword of hepatic fibrosis","volume":"115","author":"Friedman","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.lfs.2009.01.017_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiological Reviews"},{"issue":"6","key":"10.1016\/j.lfs.2009.01.017_bib13","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.lfs.2009.01.017_bib14","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1172\/JCI114362","article-title":"Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors","volume":"84","author":"Friedman","year":"1989","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.lfs.2009.01.017_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0003-2697(87)90673-7","article-title":"Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan","volume":"161","author":"Friedman","year":"1987","journal-title":"Analytical Biochemistry"},{"issue":"6","key":"10.1016\/j.lfs.2009.01.017_bib16","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hep.1840130628","article-title":"Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver","volume":"13","author":"Geerts","year":"1991","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.lfs.2009.01.017_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s001090050325","article-title":"Xenoislet transplantation: experimental and clinical aspects","volume":"77","author":"Groth","year":"1999","journal-title":"Journal of Molecular Medicine"},{"issue":"4","key":"10.1016\/j.lfs.2009.01.017_bib18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2007-991517","article-title":"Hepatic fibrogenesis","volume":"27","author":"Guo","year":"2007","journal-title":"Seminars in Liver Disease"},{"key":"10.1016\/j.lfs.2009.01.017_bib19","first-page":"591","article-title":"Pronase destroys the lipopolysaccharide receptor CD14 on Kupffer cells","volume":"276","author":"Ikejima","year":"1999","journal-title":"The American Journal of Physiology"},{"issue":"5","key":"10.1016\/j.lfs.2009.01.017_bib20","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.20438","article-title":"Leflunomide protects from T-cell-mediated liver injury in mice through inhibition of nuclear factor kappaB","volume":"40","author":"Imose","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lfs.2009.01.017_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-2001-17557","article-title":"Hepatic stellate cell behavior during resolution of liver injury","volume":"21","author":"Iredale","year":"2001","journal-title":"Seminars in Liver Disease"},{"issue":"3","key":"10.1016\/j.lfs.2009.01.017_bib22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"Iredale","year":"1998","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.lfs.2009.01.017_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/gut.48.4.548","article-title":"Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors","volume":"48","author":"Issa","year":"2001","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.lfs.2009.01.017_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1096\/fj.02-0494fje","article-title":"Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration","volume":"17","author":"Issa","year":"2003","journal-title":"The FASEB Journal"},{"issue":"7","key":"10.1016\/j.lfs.2009.01.017_bib25","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2004.03.009","article-title":"Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking","volume":"126","author":"Issa","year":"2004","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.lfs.2009.01.017_bib26","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s10495-006-9439-7","article-title":"Low dose leflunomide activates PI3K\/Akt signalling in erythroleukemia cells and reduces apoptosis induced by anticancer agents","volume":"11","author":"Leger","year":"2006","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.lfs.2009.01.017_bib27","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.4049\/jimmunol.162.4.2095","article-title":"Immunosuppressive leflunomide metabolite (A771726) blocks TNF-dependent nuclear factor-\u03baB activation and gene expression","volume":"162","author":"Manna","year":"1999","journal-title":"Journal of Immunology"},{"issue":"10","key":"10.1016\/j.lfs.2009.01.017_bib28","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.4049\/jimmunol.165.10.5962","article-title":"Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis","volume":"165","author":"Manna","year":"2000","journal-title":"Journal of Immunology"},{"issue":"4","key":"10.1016\/j.lfs.2009.01.017_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/rheumatology\/keh462","article-title":"An active metabolite of leflunomide, A771726, inhibits the production of serum amyloid A protein in human hepatocytes","volume":"44","author":"Migita","year":"2005","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.lfs.2009.01.017_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-2001-17554","article-title":"Cytokine receptors and signaling in hepatic stellate cells","volume":"21","author":"Pinzani","year":"2001","journal-title":"Seminars in Liver Disease"},{"issue":"4","key":"10.1016\/j.lfs.2009.01.017_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/35070096","article-title":"Regulation of death receptor expression and TRAIL\/Apo2L-induced apoptosis by NF-kappaB","volume":"3","author":"Ravi","year":"2001","journal-title":"Nature Cell Biology"},{"issue":"13","key":"10.1016\/j.lfs.2009.01.017_bib32","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1096\/fj.04-1847fje","article-title":"Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation","volume":"18","author":"Saxena","year":"2004","journal-title":"The FASEB Journal"},{"issue":"3","key":"10.1016\/j.lfs.2009.01.017_bib33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0168-8278(86)80481-0","article-title":"Kupffer cells from CCl4-induced fibrotic livers stimulate proliferation of fat-storing cells","volume":"3","author":"Shiratori","year":"1986","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1016\/j.lfs.2009.01.017_bib34","first-page":"427","article-title":"Suppressive effects of leflunomide on leptin-induced collagen I production involved in hepatic stellate cell proliferation","volume":"232","author":"Si","year":"2007","journal-title":"Experimental Biology and Medicine (Maywood, N.J.)"},{"issue":"5","key":"10.1016\/j.lfs.2009.01.017_bib35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jhep.2008.07.019","article-title":"The active metabolite of leflunomide, A771726, protects rat hepatocytes against bile acid-induced apoptosis","volume":"49","author":"Vrenken","year":"2008","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1016\/j.lfs.2009.01.017_bib36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1053\/gast.2001.27188","article-title":"Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats","volume":"121","author":"Wright","year":"2001","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.lfs.2009.01.017_bib37","doi-asserted-by":"crossref","first-page":"12398","DOI":"10.1074\/jbc.270.21.12398","article-title":"Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide","volume":"270","author":"Xu","year":"1995","journal-title":"The Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/j.lfs.2009.01.017_bib38","first-page":"915","article-title":"Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats","volume":"25","author":"Yao","year":"2004","journal-title":"Acta Pharmacologica Sinica"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320509000484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320509000484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T15:03:05Z","timestamp":1738940585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320509000484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":38,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0024320509000484"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2009.01.017","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}